Evolus (EOLS) FCF Margin (QoQ) (2019 - 2026)
Evolus (EOLS) FCF Margin (QoQ) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - |
| 10 | Evolus | 549.85 Mn | 504.68 Mn | 57.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1,055.00 |
| Mar 31, 2026 | -2,707.00 |
| Dec 31, 2025 | 3,646.00 |
| Sep 30, 2025 | 1,675.00 |
| Jun 30, 2025 | -1,649.00 |
| Mar 31, 2025 | -2,881.00 |
| Dec 31, 2024 | 1,442.00 |
| Sep 30, 2024 | 239.00 |
| Jun 30, 2024 | 705.00 |
| Mar 31, 2024 | -1,941.00 |
| Dec 31, 2023 | 395.00 |
| Sep 30, 2023 | 2,464.00 |
| Jun 30, 2023 | 2,238.00 |
| Mar 31, 2023 | -2,780.00 |
| Dec 31, 2022 | 2,923.00 |
| Sep 30, 2022 | 595.00 |
| Jun 30, 2022 | 5,542.00 |
| Mar 31, 2022 | -8,824.00 |
| Dec 31, 2021 | 9,811.00 |
| Sep 30, 2021 | -18,430.00 |